REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bkrs Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bkrs Pharma Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bkrs Pharma Private Limited is an unlisted company, incorporated on 17/05/2012. It has its registered office in the State of Haryana, India. Company's corporate identification number (CIN) is U24230HR2012PTC045971 and registration number is 045971. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Unit No 421, Tower B , Spazedge Commercial Complex Sohna Road , Sector 47
Gurgaon; Haryana; Postal Code: 122001

Contact Details: Purchase the Bkrs Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bkrs Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Bkrs Pharma Private Limited report to view the information.
Incorporation Date:
May 17, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Bkrs Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.12%▲
Total operating revenue
19.52%▲
Operating profit (EBIT)
-5.88%▼
EBITDA
-8.16%▼
Net Profit (Loss) for the Period
-5.99%▼
Total assets
43.77%▲
Total equity
14.8%▲
Operating Profit Margin (ROS)
-1.89%▼
Net Profit Margin
-1.34%▼
Return on Equity (ROE)
-2.85%▼
Debt to Equity Ratio
88.08%▲
Quick Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo